336 related articles for article (PubMed ID: 25654651)
21. ADAM10 is a principal 'sheddase' of the low-affinity immunoglobulin E receptor CD23.
Weskamp G; Ford JW; Sturgill J; Martin S; Docherty AJ; Swendeman S; Broadway N; Hartmann D; Saftig P; Umland S; Sehara-Fujisawa A; Black RA; Ludwig A; Becherer JD; Conrad DH; Blobel CP
Nat Immunol; 2006 Dec; 7(12):1293-8. PubMed ID: 17072319
[TBL] [Abstract][Full Text] [Related]
22. Activation of peroxisome proliferator-activated receptor α stimulates ADAM10-mediated proteolysis of APP.
Corbett GT; Gonzalez FJ; Pahan K
Proc Natl Acad Sci U S A; 2015 Jul; 112(27):8445-50. PubMed ID: 26080426
[TBL] [Abstract][Full Text] [Related]
23. Dysregulated ADAM10-Mediated Processing of APP during a Critical Time Window Leads to Synaptic Deficits in Fragile X Syndrome.
Pasciuto E; Ahmed T; Wahle T; Gardoni F; D'Andrea L; Pacini L; Jacquemont S; Tassone F; Balschun D; Dotti CG; Callaerts-Vegh Z; D'Hooge R; Müller UC; Di Luca M; De Strooper B; Bagni C
Neuron; 2015 Jul; 87(2):382-98. PubMed ID: 26182420
[TBL] [Abstract][Full Text] [Related]
24. Exendin-4 promotes the membrane trafficking of the AMPA receptor GluR1 subunit and ADAM10 in the mouse neocortex.
Ohtake N; Saito M; Eto M; Seki K
Regul Pept; 2014 May; 190-191():1-11. PubMed ID: 24769307
[TBL] [Abstract][Full Text] [Related]
25. A soluble form of the receptor for advanced glycation endproducts (RAGE) is produced by proteolytic cleavage of the membrane-bound form by the sheddase a disintegrin and metalloprotease 10 (ADAM10).
Raucci A; Cugusi S; Antonelli A; Barabino SM; Monti L; Bierhaus A; Reiss K; Saftig P; Bianchi ME
FASEB J; 2008 Oct; 22(10):3716-27. PubMed ID: 18603587
[TBL] [Abstract][Full Text] [Related]
26. Effect of a dominant-negative form of ADAM10 in a mouse model of Alzheimer's disease.
Schroeder A; Fahrenholz F; Schmitt U
J Alzheimers Dis; 2009; 16(2):309-14. PubMed ID: 19221420
[TBL] [Abstract][Full Text] [Related]
27. Anticancer chemotherapy inhibits MHC class I-related chain a ectodomain shedding by downregulating ADAM10 expression in hepatocellular carcinoma.
Kohga K; Takehara T; Tatsumi T; Miyagi T; Ishida H; Ohkawa K; Kanto T; Hiramatsu N; Hayashi N
Cancer Res; 2009 Oct; 69(20):8050-7. PubMed ID: 19826051
[TBL] [Abstract][Full Text] [Related]
28. Sox2 functionally interacts with βAPP, the βAPP intracellular domain and ADAM10 at a transcriptional level in human cells.
Sarlak G; Htoo HH; Hernandez JF; Iizasa H; Checler F; Konietzko U; Song W; Vincent B
Neuroscience; 2016 Jan; 312():153-64. PubMed ID: 26592717
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of ADAM10 promotes the clearance of Aβ across the BBB by reducing LRP1 ectodomain shedding.
Shackleton B; Crawford F; Bachmeier C
Fluids Barriers CNS; 2016 Aug; 13(1):14. PubMed ID: 27503326
[TBL] [Abstract][Full Text] [Related]
30. Role of ADAM10 and ADAM17 in CD16b shedding mediated by different stimulators.
Guo S; Peng M; Zhao Q; Zhang W
Chin Med Sci J; 2012 Jun; 27(2):73-9. PubMed ID: 22770404
[TBL] [Abstract][Full Text] [Related]
31. Systematic substrate identification indicates a central role for the metalloprotease ADAM10 in axon targeting and synapse function.
Kuhn PH; Colombo AV; Schusser B; Dreymueller D; Wetzel S; Schepers U; Herber J; Ludwig A; Kremmer E; Montag D; Müller U; Schweizer M; Saftig P; Bräse S; Lichtenthaler SF
Elife; 2016 Jan; 5():. PubMed ID: 26802628
[TBL] [Abstract][Full Text] [Related]
32. L1 is sequentially processed by two differently activated metalloproteases and presenilin/gamma-secretase and regulates neural cell adhesion, cell migration, and neurite outgrowth.
Maretzky T; Schulte M; Ludwig A; Rose-John S; Blobel C; Hartmann D; Altevogt P; Saftig P; Reiss K
Mol Cell Biol; 2005 Oct; 25(20):9040-53. PubMed ID: 16199880
[TBL] [Abstract][Full Text] [Related]
33. GPR37 is processed in the N-terminal ectodomain by ADAM10 and furin.
Mattila SO; Tuhkanen HE; Lackman JJ; Konzack A; Morató X; Argerich J; Saftig P; Ciruela F; Petäjä-Repo UE
FASEB J; 2021 Jun; 35(6):e21654. PubMed ID: 34042202
[TBL] [Abstract][Full Text] [Related]
34. Variation at the ADAM10 gene locus is not associated with Creutzfeldt-Jakob disease.
Plamont MA; Chasseigneaux S; Delasnerie-Lauprêtre N; Beaudry P; Peoc'h K; Laplanche JL
Neurosci Lett; 2003 Jun; 344(2):132-4. PubMed ID: 12782344
[TBL] [Abstract][Full Text] [Related]
35. ADAM10 regulates FasL cell surface expression and modulates FasL-induced cytotoxicity and activation-induced cell death.
Schulte M; Reiss K; Lettau M; Maretzky T; Ludwig A; Hartmann D; de Strooper B; Janssen O; Saftig P
Cell Death Differ; 2007 May; 14(5):1040-9. PubMed ID: 17290285
[TBL] [Abstract][Full Text] [Related]
36. Lack of a-disintegrin-and-metalloproteinase ADAM10 leads to intracellular accumulation and loss of shedding of the cellular prion protein in vivo.
Altmeppen HC; Prox J; Puig B; Kluth MA; Bernreuther C; Thurm D; Jorissen E; Petrowitz B; Bartsch U; De Strooper B; Saftig P; Glatzel M
Mol Neurodegener; 2011 May; 6():36. PubMed ID: 21619641
[TBL] [Abstract][Full Text] [Related]
37. ADAM10 in synaptic physiology and pathology.
Musardo S; Marcello E; Gardoni F; Di Luca M
Neurodegener Dis; 2014; 13(2-3):72-4. PubMed ID: 24008925
[TBL] [Abstract][Full Text] [Related]
38. Retinoids as a perspective in treatment of Alzheimer's disease.
Fahrenholz F; Tippmann F; Endres K
Neurodegener Dis; 2010; 7(1-3):190-2. PubMed ID: 20224284
[TBL] [Abstract][Full Text] [Related]
39. Stimulation of non-amyloidogenic processing of amyloid-β protein precursor by cryptotanshinone involves activation and translocation of ADAM10 and PKC-α.
Durairajan SS; Liu LF; Lu JH; Koo I; Maruyama K; Chung SK; Huang JD; Li M
J Alzheimers Dis; 2011; 25(2):245-62. PubMed ID: 21403388
[TBL] [Abstract][Full Text] [Related]
40. Unfolded protein response signaling by transcription factor XBP-1 regulates ADAM10 and is affected in Alzheimer's disease.
Reinhardt S; Schuck F; Grösgen S; Riemenschneider M; Hartmann T; Postina R; Grimm M; Endres K
FASEB J; 2014 Feb; 28(2):978-97. PubMed ID: 24165480
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
